Vicore Pharma to Participate in the Chardan Healthcare ConferenceAccesswire · Oct 13, 2026
Increase in Number of Shares and Votes in Vicore PharmaAccesswire · Sep 30, 2026
Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation ForumAccesswire · Sep 17, 2026
Vicore Pharma to Participate in Upcoming Healthcare ConferencesAccesswire · Sep 1, 2026
Vicore Pharma to Present at the European Respiratory Society Congress 2026Accesswire · Aug 24, 2026Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.